Make an Appointment
To make an appointment or refer a patient, call 734-936-7010.
We are now also able to provide care and expertise for patients remotely via virtual visits, and you may request this option when you call.
About the Clinic
Receiving a diagnosis of a brain tumor can be frightening. The mission of the M3BTC is to combat this fear with compassion, expertise and cutting-edge research. At the M3BTC, patients with brain tumors can be seen by expert physicians in the three specialties most crucial for successful treatment: Neurosurgery, Neuro-Oncology and Radiation Oncology.
Together, we work strategically to ensure personalized treatment recommendations that will maximize the benefits for each individual patient. Whether a patient has a new diagnosis of cancer or is seeking a second opinion after prior treatment, an appointment at the M3BTC will allow patients to access the brain tumor expertise and clinical trial options only available at Michigan Medicine.
Proper treatment of brain tumors requires the combined expertise of several medical and surgical specialists — specifically a Neurosurgeon, Neuro-Oncologist, and Radiation Oncologist.
Our clinic is dedicated to caring for a wide range of patients including the newly diagnosed, those previously treated for brain tumors, those who may have recently been discharged from the hospital and those interested in the advanced therapies available only at Michigan Medicine. We also have access to state-of-the-art clinical trials.
If you have a recent diagnosis of a brain tumor, if you are seeking a second opinion, or if you have a previous diagnosis and want to inquire about potential new treatment options, the specialists at Michigan Medicine are available with unique expertise and treatment options to meet your needs.
- Blog Post: A Brain Tumor at 27, and a Team that Changed Her Life
- Blog Post: Turning the Tables on Glioblastoma
- Blog Post: Every Day Is a Gift, Says One Patient With Brain Cancer
- Blog Post: Pilot and Marathoner Accelerates Life After Brain Tumor Surgery
- Blog Post: Brain Cancer Patient Finds Hope with Emerging New Therapy
- Rogel Cancer Center News Release: A New Way of Uncovering Predictive Biomarkers May Help Those with Rare Cancer
- Rogel Cancer Center News Release: Researchers Studying Whether an Anti-Rejection Drug Is Effective Against Glioblastoma
Brain tumors are complex and often require management by multiple specialists including Neurosurgeons, Neuro-Oncologists, and Radiation Oncologists. Historically, separate clinics within Michigan Medicine have provided the different specialty services for adult patients with brain tumors, requiring multiple referrals and separate patient appointments.
Our goal is to provide timely, efficient and comprehensive evaluation by a Neurosurgeon, Neuro-Oncologist, and Radiation Oncologist through a single point of entry. This will offer your patient an opportunity to be evaluated for eligibility for any of our clinical trials and provide a thorough consultation, including immediate access to our Brain Tumor Board discussion. Often the recommendations can be coordinated by the patient's local specialists.
This multidisciplinary team approach ensures that your patient receives comprehensive evaluations and timely recommendations during their appointments at our clinic.
- Wajd N Al-Holou, MD | Assistant Professor, Neurosurgery | M3BTC Co-Director
- Yoshie Umemura, MD | Assistant Professor, Neuro-Oncology | M3BTC Co-Director
- Daniel Wahl, MD, | Assistant Professor, Radiation Oncology | M3BTC Co-Director
- Connie McGovern | M3BTC Coordinator
- Stephanie Roath, PA-C | Physician Assistant, Neurosurgery
- Tammy Pomorski, Medical Assistant
At Michigan Medicine, we have numerous clinical trials that you may be eligible for. To set up a visit to discuss your eligibility, please contact us at 800-865-1125.
Here are a few of our featured trials for treatment of gliomas:
Multiparametric MR-Guided High Dose Adaptive Radiotherapy With Concurrent Temozolomide in Patients With Newly Diagnosed Glioblastoma
Radiation Therapy With Concomitant and Adjuvant Temozolomide Versus Radiation Therapy With Adjuvant PCV Chemotherapy in Patients With Anaplastic Glioma or Low Grade Glioma
Study of AG-881 in Participants With Residual or Recurrent Grade 2 Glioma With an IDH1 or IDH2 Mutation (INDIGO)
To see a comprehensive list of brain tumor related clinical trials at Michigan Medicine, please visit the Rogel Cancer Center Find a Clinical Trial page and search by selecting “Brain and Nervous System” from the Disease Site search drop-down.